Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,60%
1 062,40
+6,32
+0,60%
—1 056,081 055,451 067,221 044,14——
SIXC
Communications
SIXC
Communications
SIXC
-0,03%
606,74
-0,16
-0,03%
—606,90606,90610,73601,25——
SIXE
Energy
SIXE
Energy
SIXE
-1,08%
1 238,21
-13,50
-1,08%
—1 251,711 264,021 267,841 229,38——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,12%
1 718,61
-2,03
-0,12%
—1 720,641 717,521 726,381 702,65——
SIXM
Financials
SIXM
Financials
SIXM
+0,21%
637,37
+1,36
+0,21%
—636,01635,43638,14630,76——
SIXR
Staples
SIXR
Staples
SIXR
-0,96%
853,59
-8,29
-0,96%
—861,88854,93854,93841,82——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,33
+0,25
+0,11%
—218,08218,08218,46215,77——
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3 594,81
+27,84
+0,78%
—3 566,973 549,543 603,173 543,40——
SIXU
Utilities
SIXU
Utilities
SIXU
+1,03%
908,54
+9,27
+1,03%
—899,27900,59908,91897,62——
SIXV
Health care
SIXV
Health care
SIXV
+0,64%
1 495,00
+9,53
+0,64%
—1 485,471 483,471 496,661 472,99——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,64%
2 398,31
+15,25
+0,64%
—2 383,062 381,252 408,622 360,53——
BHC:NYSE
Bausch Health Companies Inc
5,45 US$
-0,91%
(-0,050) 1D
5,33 US$
-2,20% (-0,12)
After hours
Closed: 21 მაი, 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHC...
Open
5,45 US$
High
5,47 US$
Low
5,32 US$
Mkt. cap
2,04 მლრდ.
Avg. vol.
1,65 მლნ.
Volume
0,00
52-wk high
8,68 US$
52-wk low
4,41 US$
EPS
-3,24 US$
Beta
0,42
Shares outstanding
373,48 მლნ.
No. of employees
20 ათ.
News stories
From sources across the web
Profile
Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas Appio
Employees20,3 ათ.
Founded1959
Headquartersლავალი, კვებეკი, კანადა
SectorPharmaceutical industry
Websitebauschhealth.com
Last report
29 აპრ. 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
0,78 US$ / 0,69 US$
+12,81%beat
Revenue / Est. (USD)
2,52 მლრდ. / 2,41 მლრდ.
+4,84%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
2,53 მლრდ.
2,68 მლრდ.
2,80 მლრდ.
2,52 მლრდ.
Cost of goods sold
764,00 მლნ.
750,00 მლნ.
798,00 მლნ.
738,00 მლნ.
Cost of revenue
764,00 მლნ.
750,00 მლნ.
798,00 მლნ.
738,00 მლნ.
Research and development expenses
159,00 მლნ.
166,00 მლნ.
161,00 მლნ.
163,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
894,00 მლნ.
795,00 მლნ.
880,00 მლნ.
860,00 მლნ.
Operating expense
1,31 მლრდ.
1,21 მლრდ.
1,28 მლრდ.
1,26 მლრდ.
Total operating expenses
2,07 მლრდ.
1,96 მლრდ.
2,08 მლრდ.
2,00 მლრდ.
Operating income
457,00 მლნ.
717,00 მლნ.
721,00 მლნ.
521,00 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
140,00 მლნ.
218,00 მლნ.
56,00 მლნ.
-1,35 მლრდ.
EBT excluding unusual items
-25,00 მლნ.
313,00 მლნ.
322,00 მლნ.
118,00 მლნ.
Income tax expense
12,00 მლნ.
37,00 მლნ.
159,00 მლნ.
77,00 მლნ.
Effective tax rate
8,57%
16,97%
283,93%
-5,69%
Other operating expenses
-
-
-
1,00 მლნ.
Net income
148,00 მლნ.
179,00 მლნ.
-112,00 მლნ.
-1,42 მლრდ.
Net profit margin
5,85%
6,68%
-4,01%
-56,38%
Earnings per share
0,91
1,16
1,10
0,78
Interest and investment income
13,00 მლნ.
15,00 მლნ.
9,00 მლნ.
10,00 მლნ.
Interest expense
-465,00 მლნ.
-412,00 მლნ.
-397,00 მლნ.
-402,00 მლნ.
Net interest expenses
-452,00 მლნ.
-397,00 მლნ.
-388,00 მლნ.
-392,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
764,00 მლნ.
1,02 მლრდ.
1,01 მლრდ.
816,00 მლნ.
Gain or loss from assets sale
-
-6,00 მლნ.
-
-3,00 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer